Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
| Autor: | Krop, Ian E, Kim, Sung-Bae, González-Martín, Antonio, LoRusso, Patricia M, Ferrero, Jean-Marc, Smitt, Melanie, Yu, Ron, Leung, Abraham C F, Wildiers, Hans |
|---|---|
| Zdroj: | In The Lancet Oncology June 2014 15(7):689-699 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|